Cellectar reports financial results for the third quarter 2021 and provides a corporate update

Florham park, n.j., nov. 08, 2021 (globe newswire) -- cellectar biosciences, inc. (nasdaq: clrb), a late-stage clinical biopharmaceutical company focused on the discovery and development of targeted drugs for the treatment of cancer, today announced financial results for the third quarter ended september 30, 2021 and provided a corporate update.

CLRB Ratings Summary

CLRB Quant Ranking